ArticleOncogene2020

Targeting TR4 nuclear receptor with antagonist bexarotene increases docetaxel sensitivity to better suppress the metastatic castration-resistant prostate cancer progression.

Linyi Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.